Skip to main content
. 2019 Dec 18;12(1):1. doi: 10.3390/cancers12010001

Figure 3.

Figure 3

Gene signature-derived risk score could identify high-risk patients in the pooled cohort. (A) Meta-analysis indicated that patients with higher risk scores exhibited worse prognosis compared to those with lower ones (HR = 4.84, 95% CI = 2.94–6.74) in the pooled cohort. Additionally, risk scores were normalized to Z-scores in each cohort, and we observed that (B) Z-scores of risk scores were significantly elevated in BCR patients compared with BCR-free (BCR-F) patients, especially in shorter-term BCR patients.